{"transactions":[{"id":689034,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:27:05.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":89090,"price":17.1,"value":1523439.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":391489,"source":{"system":"sec-edgar","filing":"0001493152-26-037484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037484/ownership.xml","form_type":"4"}},{"id":714588,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7743,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":7743},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714587,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7741,"derivative":{"exercise_date":"2028-06-01","expiration_date":"2028-06-01","underlying":"Ordinary Shares","underlying_shares":7741},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714586,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7741,"derivative":{"exercise_date":"2027-06-01","expiration_date":"2027-06-01","underlying":"Ordinary Shares","underlying_shares":7741},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714585,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":22800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027."}],"balance_after":22800,"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714584,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":480579,"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":798709,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Elect"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:04:57.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":105416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 256,372 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (175,526 shares), July 1, 2027 (52,218 shares) and July 1, 2028 (28,628 shares)."}],"balance_after":430145,"source":{"system":"sec-edgar","filing":"0001395064-26-000128","document":"wk-form4_1777370695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000128/wk-form4_1777370695.xml","form_type":"4"}}]}